Scientists at the University of Manchester (UK) have developed the first non-antibiotic drug to successfully treat tuberculosis (TB) in animal…
Browsing: Bacterial > Tuberculosis
Financial modelling has been used to estimate the costs and likelihood of candidate medicines, vaccines, diagnostics and technologies launching, revealing gaps in the pipeline and in funding.
Guy Thwaites, Director of the Oxford University Clinical Research Unit/Wellcome Program in Vietnam, speaks on neurotuberculosis and the challenges it faces in terms of treatment, HIV co-infection and the political will necessary for change.
Take a look behind the science of a recent Future Microbiology article, entitled ‘Better than a pound of cure: preventing the development of multidrug-resistant tuberculosis’ as we ask the authors about the challenges currently facing multidrug resistant (MDR) tuberculosis and what the future might hold.
World TB Day has seen the launch of the N-TB app, a first-of-kind tool to help healthcare providers in the nutritional assessment and counselling of adult patients with tuberculosis.
TB and HIV are two intertwined infective challenges for global health and therefore they need to be addressed with an integrated approach.
We look at some of the highlights of our Twitter chat (#TalkTB), where we questioned Madhukar Pai, Nandita Venkatesan and Jacob Creswell about all things tuberculosis – from diagnosis to social stigma.
In this infographic we take a look at the diagnostics currently in the pipeline for tuberculosis, highlighting the stage of development and intended use.